Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 5 |
Descriptor
| Patients | 6 |
| Symptoms (Individual… | 6 |
| Attention Deficit… | 5 |
| Drug Therapy | 4 |
| Rating Scales | 4 |
| Adults | 3 |
| Comparative Analysis | 3 |
| Outcomes of Treatment | 3 |
| Safety | 3 |
| Children | 2 |
| Statistical Analysis | 2 |
| More ▼ | |
Author
| Adler, Lenard A. | 2 |
| Michelson, David | 2 |
| Spencer, Thomas J. | 2 |
| Adler, Lenard | 1 |
| Ball, Roberta R. | 1 |
| Biederman, Joseph | 1 |
| Busner, J. | 1 |
| Casat, C. | 1 |
| Dittmann, R. | 1 |
| Durell, Todd | 1 |
| Ebert, Dieter | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 6 |
| Reports - Research | 5 |
| Reports - Evaluative | 1 |
Education Level
Audience
Location
| Germany | 1 |
Laws, Policies, & Programs
Assessments and Surveys
| Conners Rating Scales | 6 |
| Hamilton Rating Scale for… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkMatthies, Swantje; Holzner, Sebastian; Feige, Bernd; Scheel, Corinna; Perlov, Evgeniy; Ebert, Dieter; van Elst, Ludger Tebartz; Philipsen, Alexandra – Journal of Attention Disorders, 2013
Objective: Tobacco smoking and ADHD frequently co-occur. So far, the bulk of research on the ADHD-smoking comorbidity has been done in children with ADHD and nonclinical adult samples. To assess smoking habits in adults with ADHD, the authors used the Fagerstrom Test for Nicotine Dependence (FTND). Method: In 60 adult outpatients, with an ADHD…
Descriptors: Attention Deficit Hyperactivity Disorder, Risk, Smoking, Addictive Behavior
Durell, Todd; Adler, Lenard; Wilens, Timothy; Paczkowski, Martin; Schuh, Kory – Journal of Attention Disorders, 2010
Objective: Atomoxetine is a nonstimulant medication for treating child, adolescent, and adult ADHD. This meta-analysis compared the effects in younger and older adults. Method: A post hoc analysis was conducted using data from two double-blind, placebo-controlled clinical trials. Data from patients aged 18-25 years were compared with data from…
Descriptors: Rating Scales, Older Adults, Patients, Effect Size
Adler, Lenard A.; Faraone, Stephen V.; Spencer, Thomas J.; Michelson, David; Reimherr, Frederick W.; Glatt, Stephen J.; Marchant, Barrie K.; Biederman, Joseph – Journal of Attention Disorders, 2008
Objective: Little information is available comparing self- versus investigator ratings of symptoms in adult ADHD. The authors compared the reliability, validity, and utility in a sample of adults with ADHD and also as an index of clinical improvement during treatment of self- and investigator ratings of ADHD symptoms via the Conners Adult ADHD…
Descriptors: Validity, Reliability, Rating Scales, Patients
Adler, Lenard A.; Spencer, Thomas J.; Williams, David W.; Moore, Rodney J.; Michelson, David – Journal of Attention Disorders, 2008
Objective: Previously, data from 97 weeks of open-label atomoxetine treatment of adults with attention-deficit/hyperactivity disorder (ADHD) were reported. This final report of that study presents results from over 4 years of treatment. Method: Results were derived from the study of 384 patients (125 patients remaining in the open-label trial…
Descriptors: Safety, Attention Deficit Hyperactivity Disorder, Rating Scales, Patients
Greenhill, Laurence L.; Muniz, Rafael; Ball, Roberta R.; Levine, Alan; Pestreich, Linda; Jiang, Hai – Journal of the American Academy of Child & Adolescent Psychiatry, 2006
Objective: The efficacy and safety of dexmethylphenidate extended release (d-MPH-ER) was compared to placebo in pediatric patients with attention-deficit/hyperactivity disorder (ADHD). Method: This multicenter, randomized, double-blind, placebo-controlled, parallel-group, two-phase study included 97 patients (ages 6-17 years) with…
Descriptors: Attention Deficit Hyperactivity Disorder, Safety, Child Health, Patients
Kaplan, S.; Heiligenstein, J.; West, S.; Busner, J.; Harder, D.; Dittmann, R.; Casat, C.; Wernicke, J. F. – Journal of Attention Disorders, 2004
Objective: To compare the safety and efficacy of atomoxetine, a selective inhibitor of the norepinephrine transporter, versus placebo in Attention-Deficit/Hyperactivity Disorder (ADHD) patients with comorbid Oppositional Defiant Disorder (ODD). Methods: A subset analysis of 98 children from two identical, multi-site, double-blind, randomized,…
Descriptors: Safety, Hyperactivity, Attention Deficit Disorders, Rating Scales
